DR. OLUSOLA OGUNDIPE M.D. NPI 1194849901

NPI Details

DR. Olusola Ogundipe, M.D. is a hematology and oncology internal medicine in Valparaiso, IN with 43 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Olusola Ogundipe, M.D. NPI is 1194849901. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

2600 ROOSEVELT RD
VALPARAISO, IN
ZIP 46383-970
Phone: (219) 464-1620
Fax: (219) 477-4565

The NPI 1194849901 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Urea nitrogen level to assess kidney function, quantitative (HCPCS:84520)
• Blood potassium level (HCPCS:84132)
• Blood sodium level (HCPCS:84295)
• Blood chloride level (HCPCS:82435)
• Blood creatinine level (HCPCS:82565)
• Calcium level, total (HCPCS:82310)
• Phosphatase (enzyme) level, alkaline (HCPCS:84075)
• Liver enzyme (sgpt), level (HCPCS:84460)
• Total protein level, blood (HCPCS:84155)
• Liver enzyme (sgot), level (HCPCS:84450)
• Albumin (protein) level (HCPCS:82040)
• Bilirubin level, total (HCPCS:82247)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Folic acid level, serum (HCPCS:82746)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Blood glucose (sugar) level (HCPCS:82947)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Magnesium level (HCPCS:83735)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)

The enumeration date for this NPI number is 3/19/2007 and was last updated on 4/16/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.